Skip to content

NCPDP promotes J.W. Hill to president & COO as part of leadership succession plan

The promotion marks the next phase of NCPDP's leadership transition as Lee Ann Stember prepares to retire on June 1, 2027, following her retirement announcement on Nov. 11.

SCOTTSDALE, Ariz. – The National Council for Prescription Drug Programs (NCPDP) announced the promotion of J.W. Hill, from chief operating officer to president & chief operating officer as part of the organization's long-established executive succession strategy.

Since 2017, NCPDP's Board of Trustees and executive leadership team have maintained a deliberate succession plan designed to ensure organizational continuity, operational stability and sustained leadership across the healthcare industry. Hill joined NCPDP as executive vice president and general manager with the understanding that the role would support long-term succession planning and leadership development under the guidance of CEO Lee Ann Stember.

During his tenure, Hill has played a pivotal role in advancing NCPDP's strategic priorities, modernizing operations and accelerating standards development initiatives. As COO, he has led day-to-day operations while helping position the organization to address the evolving demands of healthcare interoperability, electronic prior authorization, API strategy, patient access and emerging technologies, including artificial intelligence.

The promotion marks the next phase of NCPDP's leadership transition as Stember prepares to retire on June 1, 2027, following her retirement announcement on Nov. 11.

"This transition reflects years of thoughtful planning and leadership development to ensure continuity for our members, staff, partners and the healthcare industry," said Lee Ann Stember, CEO of NCPDP. "J.W.'s promotion to President & COO recognizes the significant contributions he has already made to the organization and positions NCPDP for a seamless leadership transition."

In his expanded role, Hill will continue overseeing organizational operations while taking on additional strategic and external leadership responsibilities alongside Stember during the transition period.

"NCPDP has been incredibly intentional in preparing for the future," Hill said. "I am honored by the trust placed in me by Lee Ann and the NCPDP Board of Trustees. I remain committed to advancing NCPDP's mission, supporting our members and strengthening the role our standards play in improving healthcare interoperability and patient care."

He added that NCPDP remains focused on advancing healthcare interoperability through standards development, collaboration, innovation and industry leadership that support patients, providers, pharmacies, payers and healthcare technology partners nationwide.

Latest